Why MacroGenics Stock Is Tanking Today
- Oops!Something went wrong.Please try again later.
- MGNX
Shares of MacroGenics (NASDAQ: MGNX) were tanking by 19.7% as of 12:22 p.m. ET on Wednesday. MacroGenics reported Q1 revenue of $11.1 million, with $3.6 million in sales of breast cancer drug Margenza and the rest from collaborative agreements. It's not surprising that the MacroGenics stock fell after it missed Q1 estimates.